Literature DB >> 1513337

Specific macromolecular interactions between tau and the microtubule system.

G A Farías1, C Vial, R B Maccioni.   

Abstract

The microtubule-associated protein Tau, a major component of brain microtubules, shares common repeated C-terminal sequences with the high molecular-weight protein MAP-2. It has been shown that tau peptides V187-G204 and V218-G235, representing two main repeats, induced brain tubulin assembly in a concentration-dependent fashion. The specific roles of these repeats in the interaction of tau with microtubules, and its antigenic nature were investigated using synthetic tau peptides and site-directed monoclonal antibodies. Tau peptides appeared to compete with MAP-2 incorporation into assembled microtubules. The interactions of the tau fragments with beta-tubulin peptides bearing the tau binding domain on tubulin were analyzed by fluorescence spectroscopy. The specificity of the binding was further demonstrated by the reactivity of tau and the tau peptides with a monoclonal anti-idiotypic antibody produced after immunization with the beta-II(422-434) tubulin peptide, as assessed by enzyme-linked immunoassay. Western blots confirmed the interaction of tau with the monoclonal antibody. In addition, immunoassays revealed a competition between the MAP-reacting monoclonal antibody and the tubulin peptide beta-II(422-434) for their interaction with the tau molecule.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1513337     DOI: 10.1007/bf00229646

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  37 in total

1.  Developmentally regulated expression of specific tau sequences.

Authors:  K S Kosik; L D Orecchio; S Bakalis; R L Neve
Journal:  Neuron       Date:  1989-04       Impact factor: 17.173

2.  Microtubule assembly in the absence of added nucleotides.

Authors:  M L Shelanski; F Gaskin; C R Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Involvement of the carboxyl-terminal domain of tubulin in the regulation of its assembly.

Authors:  L Serrano; J de la Torre; R B Maccioni; J Avila
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

5.  Microtubule-associated protein 1B: identification of a major component of the neuronal cytoskeleton.

Authors:  G S Bloom; F C Luca; R B Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

6.  A discrete repeated sequence defines a tubulin binding domain on microtubule-associated protein tau.

Authors:  R B Maccioni; J C Vera; J Dominguez; J Avila
Journal:  Arch Biochem Biophys       Date:  1989-12       Impact factor: 4.013

7.  Characterization and structural aspects of the enhanced assembly of tubulin after removal of its carboxyl-terminal domain.

Authors:  R B Maccioni; L Serrano; J Avila; J R Cann
Journal:  Eur J Biochem       Date:  1986-04-15

8.  Expression of multiple tau isoforms and microtubule bundle formation in fibroblasts transfected with a single tau cDNA.

Authors:  Y Kanai; R Takemura; T Oshima; H Mori; Y Ihara; M Yanagisawa; T Masaki; N Hirokawa
Journal:  J Cell Biol       Date:  1989-09       Impact factor: 10.539

9.  Tau protein function in living cells.

Authors:  D G Drubin; M W Kirschner
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

10.  Differential interaction of synthetic peptides from the carboxyl-terminal regulatory domain of tubulin with microtubule-associated proteins.

Authors:  R B Maccioni; C I Rivas; J C Vera
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

View more
  10 in total

1.  Differential association of tau with subsets of microtubules containing posttranslationally-modified tubulin variants in neuroblastoma cells.

Authors:  L Saragoni; P Hernández; R B Maccioni
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

2.  Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease.

Authors:  Leonel E Rojo; Jans Alzate-Morales; Iván N Saavedra; Peter Davies; Ricardo B Maccioni
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  A 205 kDa protein from non-neuronal cells in culture contains tubulin binding epitopes.

Authors:  C Vial; R Armas-Portela; J Avila; M González; R B Maccioni
Journal:  Mol Cell Biochem       Date:  1995-03-23       Impact factor: 3.396

4.  Functional domains on chemically modified tau protein.

Authors:  G A Farías; C Vial; R B Maccioni
Journal:  Cell Mol Neurobiol       Date:  1993-04       Impact factor: 5.046

5.  Carboxyl terminal sequences of beta-tubulin involved in the interaction of HMW-MAPs. Studies using site-specific antibodies.

Authors:  D Cross; G Farías; J Domínguez; J Avila; R B Maccioni
Journal:  Mol Cell Biochem       Date:  1994-03-16       Impact factor: 3.396

6.  Purification and characterization of the high molecule weight microtubule associated proteins from neonatal rat brain.

Authors:  L Guzman; R Bustos; R B Maccioni
Journal:  Mol Cell Biochem       Date:  1994-02-23       Impact factor: 3.396

7.  Immunological characterization of epitopes on tau of Alzheimer's type and chemically modified tau.

Authors:  G Farías; C González-Billault; R B Maccioni
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396

8.  The antineoplastic agent estramustine and the derivative estramustine-phosphate inhibit secretion of interleukin-3 in leukemic cells. Possible roles of MAPs.

Authors:  J Martínez; J F Santibáñez; C Vial; R B Maccioni
Journal:  Mol Cell Biochem       Date:  1992-11-18       Impact factor: 3.396

9.  Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau.

Authors:  B L Goode; S C Feinstein
Journal:  J Cell Biol       Date:  1994-03       Impact factor: 10.539

Review 10.  Proton Pump Inhibitors and Dementia: Physiopathological Mechanisms and Clinical Consequences.

Authors:  Gloria Ortiz-Guerrero; Diana Amador-Muñoz; Carlos Alberto Calderón-Ospina; Daniel López-Fuentes; Mauricio Orlando Nava Mesa
Journal:  Neural Plast       Date:  2018-03-21       Impact factor: 3.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.